Skip to Main Content

Paper Details

Safety issues and adverse reactions with osteoporosis management.
Expert Opinion on Drug Safety
32
2016
Bisphosphonates, Calcitonin, Calcium, Denosumab, Estrogen, Estrogen Receptor, Osteoporosis, Strontium ranelate, Teriparatide, Vitamin D, fragility fractures, osteoporosis, patients
Author NameAffiliation
Silvano AdamiUniversity of Verona
  • 1 - 1

Datasets

Release 1.2